Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clones

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 1055-1060

  Essayan, David M ^a,b   Kagey Sobotka, Anne ^a   Lichtenstein, Lawrence M ^a   Huang, Shau Ku ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

allergy; cAMP; human; interleukin 13; phosphodiesterase; T lymphocyte

Indexed keywords

CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; INTERLEUKIN 13; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SIGUAZODAN;

ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; T LYMPHOCYTE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ALLERGENS; CLONE CELLS; GENE EXPRESSION; GLYCOPROTEINS; GUANIDINES; HUMANS; INTERLEUKIN-13; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHOSPHODIESTERASE INHIBITORS; PYRIDAZINES; PYRROLIDINONES; ROLIPRAM;

EID: 0030919713     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00102-0     Document Type: Article

References (24)

1. de Vries JE and Zurawski G, Immunoregulatory properties of IL-13: Its potential role in atopic disease. Int Arch Allergy Immunol 106: 175-179, 1995.
2. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R and de Vries JE, Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Nad Acad Sci USA 90: 3730-3734, 1993.
3. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL and Schleimer RP, IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154: 799-803, 1995.
4. Magazin M, Guillemot JC, Vita N and Ferrara P, Interleukin-13 is a monocyte chemoattractant. Eur Cytokine Netw 5: 397-400, 1994.
5. Vita N, Lefort S, Laurent P, Caput D and Ferrara P, Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270: 3512-3517, 1995.
6. Smerz-Bertling C and Duschl A, Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem 270: 966-970, 1995.
7. Adunyah SE, Pegram ML and Cooper RS, Interleukin-13 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937. Biochem Biophys Res Commun 206: 103-111, 1995.
8. + 45RO-T cells develop into effector cells that secrete IL-13, 1L-5, and IFN-γ, but no IL-4, and help efficient IgE production by B cells. J Immunol 154: 3078-3087, 1995.
9. Huang S-K, Xiao HQ, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM and Liu MC, IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155: 2688-2694, 1995.
10. Novak TJ and Rothenberg EV, cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 87: 9353-9357, 1990.
11. Krause DS and Deutsch C, Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: Expression of both p55 and p75 subunits is affected. J Immunol 146: 2285-2294, 1991.
12. Chan SC, Li SH and Hanifin JM, Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 100: 681-684, 1993.
13. Maghazachi AA, Tumor necrosis factor-a is chemokinetic for lymphokine-activated killer cells: Regulation by cyclic adenosine monophosphate. J Leukoc Biol 49: 302-308, 1991.
14. Torphy TJ, Zhou H-L and Cieslinski LB, Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 263: 1195-1205, 1992.
15. Essayan DM and Lichtenstein LM, Phosphodiesterase inhibitors: Yesterday, today, and tomorrow. Insights Allergy 9: 2-11, 1994.
16. Essayan DM, Huang S-K, Undem BJ, Kagey-Sobotka A and Lichtenstein LM, Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J Immunol 153: 3408-3416, 1994.
17. Essayan DM, Huang S-K, Kagey-Sobotka A and Lichtenstein LM, Effects of nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors on antigen-induced cytokine gene expression in peripheral blood mononuclear cells. Am J Respir Cell Mol Biol 13: 692-702, 1995.
18. Huang S-K, Zwollo P and Marsh DG, Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V. Eur J Immunol 21: 1469-1473, 1991.
19. Essayan DM, Han W-F, Li X-M, Xiao H-Q, Kleine-Tebbe J and Huang S-K, Clonal diversity of interleukin-4 and interleukin-13 expression in human allergen-specific T lymphocytes. J Allergy Clin Immunol 98: 1035-1044, 1996.
20. Huang S-K, Essayan DM, Krishnaswamy G, Yi M, Kumai M, Su S-N, Xiao H-Q, Lichtenstein LM and Liu MC, Detection of allergen- and mitogen-induced human cytokine transcripts using a competitive polymerase chain reaction. J Immunol Methods 168: 167-181, 1994.
21. Akridge RE, Oyafuso LKM and Reed SG, IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 153: 5782-5789, 1994.
22. Ohmn JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC and Modlin RL, Overproduction of IL-10 in atopic dermatitis: Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154: 1956-1963, 1995.
23. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA and Miossec P, Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154: 1432-1439, 1995.
24. Essayan DM, Kagey-Sobotka A, Lichtenstein LM and Huang S-K, Effects of lymphocyte and/or monocyte pretreatment with a type IV phosphodiesterase (PDE) inhibitor on antigen-driven proliferation and cytokine gene expression. J Allergy Clin Immunol 99: 28-37, 1997.